6,7-Dimethoxycoumarin Influences the Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells through Regulating FOXO3/p27 Signal Pathway. The gene discussed is CDKN1B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.